Quantcast

Latest Hypnotics Stories

2011-06-13 14:43:34

Study finds that treatment with frontal cerebral thermal transfer can eliminate insomnia symptoms People with primary insomnia may be able to find relief by wearing a cap that cools the brain during sleep, suggests a research abstract that will be presented Monday, June 13, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC (APSS). According to the authors, a reduction in metabolism in the brain's frontal cortex occurs while...

2011-06-06 16:00:00

MORRISTOWN, N.J., June 6, 2011 /PRNewswire/ -- Actavis, an international generic pharmaceuticals company, today announced that it has received final approval from the US Food & Drug Administration to market Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV. Distribution of the product has commenced. Actavis was the first company to launch Zolpidem Tartrate Extended-Release Tablets 6.25 mg strength in October 2010 with 180-day exclusivity. Zolpidem Tartrate...

2011-04-22 00:00:30

The Effortless Sleep Method, a book detailing a new, natural insomnia treatment method is now available at Amazon. (PRWEB) April 21, 2011 The Effortless Sleep Method, a book detailing a new, natural insomnia treatment method is now available at Amazon. Sasha Stephens, Sleep Therapist, author of Effortless-Sleep.com and the Effortless Sleep Method book is excited to have her insomnia treatment method available through Amazon. Sasha Stephens comments, "The Effortless Sleep Method has helped...

2011-04-20 08:00:00

SAN DIEGO, April 20, 2011 /PRNewswire/ -- Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection. Through the collaboration with the University of Minnesota and James Cloyd, PharmD; Neurelis has partnered with the leading experts in clinical research of the nasal delivery of benzodiazepines....

2011-04-18 05:30:00

ANAHEIM, Calif., April 18, 2011 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it will release first quarter 2011 financial results on Tuesday, April 26, 2011 after the close of the U.S. financial markets. The Company will host a conference call and webcast on Tuesday, April 26, 2011 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss results and highlights of the first quarter, as well as current corporate developments. Conference...

2011-03-29 05:30:00

ANAHEIM, Calif., March 29, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that executive management will present at the Needham Healthcare Conference to be held April 5-6, 2011 at the New York Palace Hotel in New York City. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Tuesday, April 5, 2011 at 8:00 a.m. ET. To listen to the audio web cast of the presentation during or after the event,...

2011-03-28 21:44:44

Conventional antipsychotics, antidepressants and benzodiazepines often administered to nursing home residents are no safer than atypical antipsychotics and may carry increased risks, according to an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj101406.pdf. Psychotropic medications are often used to manage behavioral symptoms in seniors, particularly people with dementing illnesses, with up to two-thirds of dementia patients in...

2011-03-09 05:30:00

ANAHEIM, Calif., March 9, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that executive management will present at the Barclays Capital Global Healthcare Conference to be held March 15-17, 2011 at the Loews Miami Hotel in Miami, Florida. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Wednesday, March 16, 2011 at 2:30 p.m. ET. To listen to the audio web cast of the presentation during or after...

2011-03-04 15:05:00

ANAHEIM, Calif., March 4, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) has completed a formal selection process and appointed BDO USA, LLP ("BDO") as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements. Questcor has selected BDO to replace Odenberg Ullakko Muranishi & Co. LLP ("OUM") as its independent registered public accounting firm. "As we continue our strategy to grow through increased sales of...

2011-03-02 07:20:00

FREMONT, Calif., March 2, 2011 /PRNewswire/ -- Handa Pharmaceuticals, LLC ("Handa"), a specialty pharmaceutical company based in Fremont, California, today confirmed that its Abbreviated New Drug Application ("ANDA") for Dexlansoprazole Delayed Release Capsules, 60 mg, a generic version of Takeda's DEXILANT®, has been accepted for review by the U.S. Food and Drug Administration ("FDA"). Based upon available information, Handa believes that it is the first applicant to file...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related